Preclinical and clinical studies for transplant tolerance via the mixed chimerism approach
Authors:
- 1 May 2018
- journal article
- review article
- Published by Elsevier in Human Immunology
- Vol. 79 (5) , 258-265
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Diabetes and Digestive and Kidney Diseases
This publication has 32 references indexed in Scilit:
- Alefacept promotes co-stimulation blockade based allograft survival in nonhuman primatesNature Medicine, 2009
- HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation CyclophosphamideTransplantation and Cellular Therapy, 2008
- HLA-Mismatched Renal Transplantation without Maintenance ImmunosuppressionNew England Journal of Medicine, 2008
- Cardiovascular Toxicities of Immunosuppressive AgentsAmerican Journal of Transplantation, 2002
- Strategies to Improve Long-Term Outcomes after Renal TransplantationNew England Journal of Medicine, 2002
- Improved Graft Survival after Renal Transplantation in the United States, 1988 to 1996New England Journal of Medicine, 2000
- Thromboembolic complications after treatment with monoclonal antibody against CD40 ligandNature Medicine, 2000
- A RANDOMIZED, DOUBLE-BLINDED COMPARISON OF THYMOGLOBULIN VERSUS ATGAM FOR INDUCTION IMMUNOSUPPRESSIVE THERAPY IN ADULT RENAL TRANSPLANT RECIPIENTS1,2Transplantation, 1999
- Risk of neoplasia in renal transplant patientsThe Lancet, 1995
- Mixed Allogeneic Chimerism And Renal Allograft Tolerance In Cynomolgus MonkeysTransplantation, 1995